Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0722
+0.0221 (44.11%)
At close: Mar 17, 2026
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $412.66 thousand as of March 19, 2026. Its market cap has decreased by -73.62% in one year.
Market Cap
412.66K
Enterprise Value
1.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 412.66K, a decrease of -99.76%. That is a compound annual growth rate of -40.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 412.66K | -21.94% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Windtree Therapeutics | 726.30K |
| SQZ Biotechnologies Company | 707.79K |
| Bio-Path Holdings | 554.92K |
| Avenue Therapeutics | 505.73K |
| Hepion Pharmaceuticals | 503.16K |
| Aibotics | 485.43K |
| Actavia Life Sciences | 385.91K |
| Regenerative Medical Technology Group | 375.77K |